{
  "created_at": "Wed Jun 23 22:43:49 +0000 2021",
  "id_str": "1407826484501307392",
  "full_text": "A second jab appears to be particularly protective against the delta variant, a study using Pfizer-BioNTech or AstraZeneca vaccines suggests https://t.co/7mjKQMPWCE",
  "display_text_range": [
    0,
    164
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/7mjKQMPWCE",
        "expanded_url": "https://econ.st/3xCxlW2",
        "display_url": "econ.st/3xCxlW2",
        "indices": [
          141,
          164
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 32,
  "favorite_count": 94,
  "possibly_sensitive": false,
  "original_created_at": "Wed Jun 23 22:22:44 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "ファイザー・バイオンテック社とアストラゼネカ社のワクチンを使用した研究では、2回目のワクチンがデルタ型に対して特に有効であることが示唆されている。https://t.co/7mjKQMPWCE"
    },
    {
      "locale": "zh",
      "full_text": "使用辉瑞-生物技术公司或阿斯利康公司的疫苗进行的一项研究表明，第二针似乎对delta变体特别有保护作用https://t.co/7mjKQMPWCE。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "使用輝瑞-生物技術公司或阿斯利康公司的疫苗進行的一項研究表明，第二針似乎對delta變體特別有保護作用https://t.co/7mjKQMPWCE。"
    }
  ]
}